PGAM
NMTC icon

Princeton Global Asset Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Princeton Global Asset Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.53K Sell
2,805
-1
-0% -$4 ﹤0.01% 606
2026
Q1 		$13.1K Hold
2,806
– – ﹤0.01% 547
2025
Q4 		$12.8K Hold
2,806
– – ﹤0.01% 554
2025
Q3 		$15K Hold
2,806
– – ﹤0.01% 484
2025
Q2 		$11.4K Hold
2,806
– – ﹤0.01% 506
2025
Q1 		$14.3K Hold
2,806
– – ﹤0.01% 429
2024
Q4 		$13.9K Hold
2,806
– – ﹤0.01% 456
2024
Q3 		$16.7K Hold
2,806
– – ﹤0.01% 442
2024
Q2 		$13.5K Hold
2,806
– – ﹤0.01% 432
2024
Q1 		$20.2K Hold
2,806
– – ﹤0.01% 362
2023
Q4 		$26.6K Hold
2,806
– – 0.01% 327
2023
Q3 		$15K Hold
2,806
– – ﹤0.01% 364
2023
Q2 		$20.2K Hold
2,806
– – 0.01% 340
2023
Q1 		$27.1K Buy
+2,806
New +$26K 0.01% 320

Other funds holding NMTC

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Princeton Global Asset Management's NMTC Position: Q2 2026 in Review

Princeton Global Asset Management reduced its NeuroOne Medical Technologies (NMTC) stake by 0.04% in Q2 2026, selling an estimated $4 and leaving 2,805 shares worth $8.53K. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Princeton Global Asset Management first reported a position in NMTC in Q1 2023 and has held it in 14 quarters since. The position peaked at $27.1K in Q1 2023. 3 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Princeton Global Asset Management held 2,805 shares of NeuroOne Medical Technologies worth $8.53K as of Q2 2026.
  • Princeton Global Asset Management sold 1 NeuroOne Medical Technologies share in Q2 2026, an estimated $4.
  • NeuroOne Medical Technologies made up ﹤0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #606 holding.
  • Princeton Global Asset Management first reported a position in NeuroOne Medical Technologies in Q1 2023 and has held it in 14 quarters since.
  • Princeton Global Asset Management's NeuroOne Medical Technologies position peaked at $27.1K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.